PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Closed-Loop Digital Framework Cuts Controlled Substance Documentation Gaps

controlled substancesnarcotic drugsclass 1 psychotropicsmedication safetyclosed-loop managementbarcode medication administrationbatch traceabilityempty-ampoule recoverydiversion preventionquality improvementhealth informaticsHIMSS EMRAMpre-post study Medication Safety

Background Information

Improving controlled substance safety with a 3D closed-loop framework.

Controlled substances require meticulous management to ensure safety and compliance in healthcare settings. Prescription dispensing record compliance increased from 94.82% to 98.7%, and batch-number management noncompliance decreased from 2.4% to 0.6%. The 3D closed-loop framework showed significant improvements in controlled substance management but requires further multicenter validation for broader application. The framework enhanced controlled substance management in a digitally mature hospital, warranting further testing for broader use.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Sun N, Su J, Yu Q, Xu Y, Zhuo M

Citation: Sun N, Su J, Yu Q, et al. A Quantifiable 3D Closed-Loop Framework for Controlled Substance Safety in a HIMSS Electronic Medical Record Adoption Model (EMRAM) Stage 7 Hospital: Pre-Post Quality Improvement Study. JMIR medical informatics. 2026;14:e98247. doi:10.2196/98247

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.